Nyaradzo Mgodi

Also affiliated with University of California, San Francisco

MedicineImmunology and MicrobiologyHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 51 papers. Top paper: “Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial”.

Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial

The Lancet(2022)10.1016/s0140-6736(22)00538-4

N/A

7.4DataRank · unranked

552 citations

James P. Hughes, Peter Bock, Samuel Gurrion Ouma, Portia Hunidzarira, Dishiki Kalonji +95 more

Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

New England Journal of Medicine(2021)10.1056/nejmoa2031738

N/A

6.2DataRank · unranked

547 citations

Peter B. Gilbert, Michal Juraska, David C. Montefiori, Lynn Morris, Shelly Karuna +40 more

PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial

PLoS Medicine(2021)10.1371/journal.pmed.1003670

N/A

4.7DataRank · unranked

180 citations

Sybil Hosek, Mandisa Tsholwana, Sheetal Kassim, Shorai Mukaka, Bonnie J. Dye +17 more

Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study

The Lancet HIV(2021)10.1016/s2352-3018(20)30304-0

N/A

2.4DataRank · unranked

111 citations

Thesla Palanee‐Phillips, Nyaradzo Mgodi, Ashley Mayo, Daniel Szydlo, Gita Ramjee +91 more

High prevalence and incidence of gonorrhoea and chlamydia in young women eligible for HIV pre-exposure prophylaxis in South Africa and Zimbabwe: results from the HPTN 082 trial

Sexually Transmitted Infections(2023)10.1136/sextrans-2022-055696

N/A

0.814DataRank · unranked

25 citations

Nyaradzo Mgodi, Linda‐Gail Bekker, Jared M. Baeten, Chuwen Li, Deborah Donnell +9 more

Estimated costs for the delivery of safer conception strategies for HIV-discordant couples in Zimbabwe: a cost analysis

BMC Health Services Research(2020)10.1186/s12913-020-05784-4

N/A

0.542DataRank · unranked

13 citations

Joelle Brown, Caroline Murombedzi, Thandiwe Chirenda, Gift Chareka, Felix Mhlanga +8 more

Safety and drug quantification of the dapivirine vaginal ring and oral pre-exposure prophylaxis in breastfeeding mother–infant pairs (MTN-043): a phase 3B, open-label, randomised trial

The Lancet HIV(2025)10.1016/s2352-3018(24)00306-0

N/A

0.518DataRank · unranked

13 citations

Maxensia Owor, Nyaradzo Mgodi, Brenda Gati Mirembe, Sufia Dadabhai, Elizea Horne +14 more

High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials

Nature Communications(2023)10.1038/s41467-023-43384-y

N/A

0.515DataRank · unranked

22 citations

Bryan T. Mayer, Allan C. deCamp, Yunda Huang, Bo Zhang, Lindsay N. Carpp +28 more

Preventing HIV and achieving pregnancy among HIV sero-different couples: Pilot study of a safer conception intervention in Zimbabwe

PLOS Global Public Health(2023)10.1371/journal.pgph.0000796

N/A

0.468DataRank · unranked

14 citations

Serah Gitome, Bismark Mataveke, Thandiwe Chirenda, Allen Matubu, Gift Chareka +15 more

Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial

PLoS Medicine(2024)10.1371/journal.pmed.1004360

N/A

0.439DataRank · unranked

9 citations

Erica Andersen‐Nissen, Nicole Grunenberg, One Dintwe, Faatima Laher Omar, Jia Jin Kee +29 more

Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study

EClinicalMedicine(2025)10.1016/j.eclinm.2024.103054

N/A

0.269DataRank · unranked

5 citations

Asa Tapley, Aaron Hudson, Sufia Dadabhai, Bo Zhang, Nyaradzo Mgodi +93 more

Safety outcomes among infants whose mothers used the dapivirine vaginal ring or oral PrEP during pregnancy (MTN-042/DELIVER): a randomised phase 3b study

The Lancet HIV(2025)10.1016/s2352-3018(25)00261-9

N/A

0.208DataRank · unranked

3 citations

Daniel Szydlo, Ashley Mayo, Katie Bunge, Felix Mhlanga, Jeanna Piper +57 more

Assessing Per-Sex-Act HIV-1 Risk Reduction Among Women Using the Dapivirine Vaginal Ring

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad550

N/A

0.173DataRank · unranked

2 citations

Tracy Qi Dong, Craig W. Hendrix, Thesla Palanee‐Phillips, Ariane van der Straten, Sharon L. Hillier +22 more

Correlates of Dapivirine Vaginal Ring Acceptance among Women Participating in an Open Label Extension Trial

AIDS and Behavior(2022)10.1007/s10461-022-03841-z

N/A

0DataRank · unranked

4 citations

Maria Valdez Cabrera, Ariane van der Straten, Rita Nakalega, Mandy Rae Cobbing, Nyaradzo Mgodi +13 more

Couples’ decision making regarding the use of multipurpose prevention technology (MPT) for pregnancy and HIV prevention

AIDS and Behavior(2022)10.1007/s10461-022-03756-9

N/A

0DataRank · unranked

5 citations

Erica N. Browne, Juliane Etima, Petina Musara, Miriam Hartmann, Mary Kate Shapley‐Quinn +9 more

Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials

PLoS Pathogens(2023)10.1371/journal.ppat.1011469

N/A

0DataRank · unranked

56 citations

Anna Yssel, Haajira Kaldine, Rebecca T. van Dorsten, Amanda S. Woodward Davis, Nicolas Beaume +35 more

DELIVER: A Safety Study of a Dapivirine Vaginal Ring and Oral PrEP for the Prevention of HIV During Pregnancy

JAIDS Journal of Acquired Immune Deficiency Syndromes(2023)10.1097/qai.0000000000003312

N/A

0DataRank · unranked

34 citations

Jennifer E. Balkus, Lee Fairlie, Ashley Mayo, Clemensia Nakabiito, Nyaradzo Mgodi +9 more

Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition

EBioMedicine(2023)10.1016/j.ebiom.2023.104590

N/A

0DataRank · unranked

33 citations

Yunda Huang, Shelly Karuna, Jack Heptinstall, Caroline Brackett, Kelvin Chiong +40 more

Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in women

Journal of the International AIDS Society(2023)10.1002/jia2.26118

N/A

0DataRank · unranked

11 citations

Fei Gao, James P. Hughes, Brett Hanscom, Lawrence Corey, Myron S. Cohen +9 more

Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials

UNC Libraries(2023)10.17615/nx73-wv26

N/A

0DataRank · unranked

0 citations

John Hural, Ruwayhida Thebus, Amanda Eaton, Shelly Karuna, Myron S. Cohen +35 more

Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial

UNC Libraries(2023)10.17615/9m9q-rf23

N/A

0DataRank · unranked

0 citations

Bekezela Siziba, Dishiki Kalonji, M.C. Hosseinipour, S. Delany-Moretlwe, C.W. Hendrix +35 more

Prediction of serum HIV-1 neutralization titers of VRC01 in HIV-uninfected Antibody Mediated Prevention (AMP) trial participants

UNC Libraries(2023)10.17615/q13b-q658

N/A

0DataRank · unranked

0 citations

Srilatha Edupuganti, Shelly Karuna, Michal Juraska, Nonhlanhla N. Mkhize, P. Andrew +16 more

A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline Findings

UNC Libraries(2023)10.17615/42e2-fv64

N/A

0DataRank · unranked

0 citations

Simbarashe Takuva, Nyaradzo Mgodi, Srilatha Edupuganti, Gomez Lorenzo, M.M., Maurine D. Miner +24 more

Pharmacokinetics and predicted neutralisation coverage of VRC01 in HIV-uninfected participants of the Antibody Mediated Prevention (AMP) trials

UNC Libraries(2023)10.17615/f8gd-ra57

N/A

0DataRank · unranked

0 citations

Paula González, Kathryn Mngadi, John R. Mascola, L. Naidoo, Peter B. Gilbert +18 more

“ First was to sit down and bring our minds together ”. A qualitative study on safer conception decision-making among HIV sero-different couples in Zimbabwe

Sexual and Reproductive Health Matters(2024)10.1080/26410397.2024.2366587

N/A

0DataRank · unranked

3 citations

Petina Musara, Miria Chitukuta, Felix Mhlanga, Bismark Mateveke, Thandiwe Chirenda +16 more

“We chose PrEP because I wanted to be sure that this child my wife was going to conceive was indeed mine.” Factors influencing the choice of safer conception methods and experiences with its use: a qualitative study among HIV sero-discordant couples in Zimbabwe

BMC Public Health(2024)10.1186/s12889-024-19155-9

N/A

0DataRank · unranked

3 citations

Petina Musara, Serah Gitome, Miria Chitukuta, Bismark Mataveke, Thandiwe Chirenda +16 more

Perception of couples’ on multipurpose prevention technology attribute choice: the case of MTN 045

BMC Public Health(2024)10.1186/s12889-024-19390-0

N/A

0DataRank · unranked

1 citations

Alinda M. Young, Petina Musara, Mary Kate Shapley‐Quinn, Doreen Kemigisha, Prisca Mutero +4 more

Intimate partner violence and oral HIV pre-exposure prophylaxis adherence among young African women

UNC Libraries(2024)10.17615/vnkv-3029

N/A

0DataRank · unranked

0 citations

S. Hosek, A. Pettifor, S. Delany-Moretlwe, Linda‐Gail Bekker, C. Celum +7 more

Perception of couples’ on multipurpose prevention technology attribute choice: the case of MTN 045

UNC Libraries(2024)10.17615/zywh-gr95

N/A

0DataRank · unranked

0 citations

Mary Kate Shapley‐Quinn, Adlight Dandadzi, Petina Musara, Prisca Mutero, Juliane Etima +4 more

Evaluation of long‐acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084

Journal of the International AIDS Society(2025)10.1002/jia2.26401

N/A

0DataRank · unranked

17 citations

Brett Hanscom, Xu Guo, Clemensia Nkabiito, Patricia Mandima, Patricia Ntege Nahirya +17 more

Rare twin cysteine residues in the HIV-1 envelope variable region 1 link to neutralization escape and breadth development

Cell Host & Microbe(2025)10.1016/j.chom.2025.01.004

N/A

0DataRank · unranked

3 citations

Marius Zeeb, Peter Rusert, Chloé Pasin, Jennifer L. Mamrosh, Samuel Mundia Kariuki +33 more

“…this could be a noble idea and a game changer.” The potential of a dual prevention pill for HIV and pregnancy prevention among adolescent girls and young women in Zimbabwe

PLOS Global Public Health(2025)10.1371/journal.pgph.0005071

N/A

0DataRank · unranked

1 citations

Sanyukta Mathur, Petina Musara, Irene Bruce, Lorna Begg, Natasha Sedze +4 more

Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV

Nature Communications(2025)10.1038/s41467-025-63948-4

N/A

0DataRank · unranked

1 citations

Bo Zhang, Caroline Brackett, Peter Elyanu, Asa Tapley, Sufia Dadabhai +95 more

Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.07.01.659979

N/A

0DataRank · unranked

1 citations

Chivonne Moodley, Craig A. Magaret, Elena Giorgi, Morgane Rolland, Dylan H. Westfall +43 more

VRC01 Selects Rare HIV Escape Mutations After Acquisition in Antibody-Mediated Prevention Trials

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.10.29.685411

N/A

0DataRank · unranked

1 citations

Lyle Curry, Nonhlanhla N. Mkhize, Elena Giorgi, Craig A. Magaret, Bronwen E. Lambson +44 more

Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition

UNC Libraries(2025)10.17615/19xw-z883

N/A

0DataRank · unranked

0 citations

José A. Hidalgo, Fatima Laher, John Hural, Nicole L. Yates, Caroline Brackett +40 more

Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in women

UNC Libraries(2025)10.17615/8kk4-f682

N/A

0DataRank · unranked

0 citations

Jared M. Baeten, Deborah Donnell, Glenda Gray, Linda‐Gail Bekker, Srilatha Edupuganti +9 more

Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study

UNC Libraries(2025)10.17615/p4hj-9n46

N/A

0DataRank · unranked

0 citations

Jia Jin Kee, Mubiana Inambao, Essack Mitha, Dishiki Kalonji, William Brumskine +76 more

Engagement of adolescent girls and young women into an early oral PrEP open-label study in Southern Africa: lessons learned from HPTN 082

BMC Public Health(2025)10.1186/s12889-025-24890-8

N/A

0DataRank · unranked

0 citations

Nomsa Mhlanga, Sisa Nobanda, Charles Chasakara, Ntando Yola, Kathy Hinson +10 more

Elevated Risk of Bacterial Vaginosis Among Users of the Copper Intrauterine Device: A Prospective Longitudinal Cohort Study

Clinical Infectious Diseases(2020)10.1093/cid/ciaa703

N/A

0DataRank · unranked

44 citations

Flavia Matovu Kiweewa, Thesla Palanee‐Phillips, Catherine A. Chappell, Devika Singh, Katherine Bunge +23 more

Safety and tolerability of injectable Rilpivirine LA in HPTN 076: A phase 2 HIV pre-exposure prophylaxis study in women

EClinicalMedicine(2020)10.1016/j.eclinm.2020.100303

N/A

0DataRank · unranked

24 citations

SHUANGLING LI, Subash Pathak, Elizabeth E. Tolley, Mark A. Marzinke, Jessica Justman +13 more

Estimated costs for the delivery of safer conception strategies for HIV-discordant couples in Zimbabwe: A cost analysis

Research Square(2020)10.21203/rs.3.rs-34096/v1

N/A

0DataRank · unranked

0 citations

Joelle Brown, Caroline Murombedzi, Thandiwe Chirenda, Gift Chareka, Felix Mhlanga +8 more

Estimated costs for the delivery of safer conception strategies for HIV-discordant couples in Zimbabwe: A cost analysis

Research Square(2020)10.21203/rs.3.rs-34096/v2

N/A

0DataRank · unranked

0 citations

Joelle Brown, Caroline Murombedzi, Thandiwe Chirenda, Gift Chareka, Felix Mhlanga +8 more

Estimated costs for the delivery of safer conception strategies for HIV-discordant couples in Zimbabwe: A cost analysis

Research Square(2020)10.21203/rs.3.rs-34096/v3

N/A

0DataRank · unranked

0 citations

Joelle Brown, Caroline Murombedzi, Thandiwe Chirenda, Gift Chareka, Felix Mhlanga +8 more

Bacterial Vaginosis and the Risk of Trichomonas vaginalis Acquisition Among HIV-1–Negative Women

UNC Libraries(2020)10.17615/q1xc-nb22

N/A

0DataRank · unranked

0 citations

Salim S. Abdool Karim, Gita Ramjee, Irving Hoffman, Lorna K. Rabe, Taha E. Taha +4 more

Pharmacokinetics and predicted neutralisation coverage of VRC01 in HIV-uninfected participants of the Antibody Mediated Prevention (AMP) trials

EBioMedicine(2021)10.1016/j.ebiom.2020.103203

N/A

0DataRank · unranked

29 citations

Logashvari Naidoo, Lily Zhang, Lindsay N. Carpp, Erika Rudnicki, April K. Randhawa +18 more

Assessing pregnancy and neonatal outcomes in Malawi, South Africa, Uganda, and Zimbabwe: Results from a systematic chart review

PLoS ONE(2021)10.1371/journal.pone.0248423

N/A

0DataRank · unranked

17 citations

Moni B. Neradilek, Lee Fairlie, Bonus Makanani, Nyaradzo Mgodi, Felix Mhlanga +7 more

The Influence of Perceived Dapivirine Vaginal Ring Effectiveness on Social Disclosure and Ring Adherence

AIDS and Behavior(2021)10.1007/s10461-021-03286-w

N/A

0DataRank · unranked

6 citations

Elizabeth R. Brown, Thesla Palanee‐Phillips, Leila E. Mansoor, Tchangani Tembo, Gonasagrie Nair +28 more

High Asymptomatic Carriage With the Omicron Variant in South Africa

Clinical Infectious Diseases(2022)10.1093/cid/ciac237

N/A

0DataRank · unranked

81 citations

Asa Tapley, Jessica Andriesen, Ishen Seocharan, Leigh H. Fisher, Lisa Bunts +85 more

Impact of catch-up human papillomavirus vaccination on cervical cancer incidence in Kenya: A mathematical modeling evaluation of HPV vaccination strategies in the context of moderate HIV prevalence

EClinicalMedicine(2022)10.1016/j.eclinm.2022.101306

N/A

0DataRank · unranked

32 citations

Nelly Mugo, Cara J. Bayer, Darcy W. Rao, Maricianah Onono, Nyaradzo Mgodi +6 more

Couples’ Preferences for “2 in 1” Multipurpose Prevention Technologies to Prevent Both HIV and Pregnancy: Results of a Discrete Choice Experiment in Uganda and Zimbabwe

AIDS and Behavior(2022)10.1007/s10461-022-03713-6

N/A

0DataRank · unranked

20 citations

Juliane Etima, Petina Musara, Erica N. Browne, Prisca Mutero, Doreen Kemigisha +9 more